Coagulopathies in Trauma and Major Bleeding: The Clinical Perspective

Read full text Summarise with VIRAT
Authors: Fabrizio Bonanno
Cited by: 0
References: 124

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Coagulopathy in trauma or major bleeding is not a frequent phenomenon. Commonly known as TIC (trauma-induced coagulopathy), it can be subclinical and identifiable only with lab tests or clinically manifesting as diffuse oozing from mucosae or parenchymal organs. Other coagulopathies, varying from low or dysfunctional platelets, low fibrinogen, or hyperfibrinolysis; preexisting deficiency of coagulation factors; or current use of anti-platelets or antithrombotic drugs, can also be present in trauma and major bleeding scenarios. Contrary to the predominant narrative of the last three decades, TIC does not increase bleeding rate and mortality, nor can any anti-coagulopathy therapy or pro-coagulant drug reduce the bleeding rate and mortality of hemorrhagic shock (HS). The only exception and benefit from its earliest identification by viscoelastic hemostatic assays (VHA) in the first 10 min has been found in mild-to-moderate traumatic brain injury, where its management reduces mortality by not lowering the threshold for surgical intervention. Any pro-coagulant or anti-coagulopathy therapy can be given early and preoperatively in established mild-to-moderate compensated stable HS before source control, but it should be administered only after source control in advanced, progressing, unstable HS as it would otherwise get lost through the solution of continuity of the vascular system. In all other situations, conventional coagulation assays (CCA) within 45–60 min suffice to identify a coagulopathy and target specific management with beneficial reduction of blood components’ postoperative requirements. Coagulopathies per se are manageable and not lethal, and in no way should be deemed as criterion for damage control surgery.

Fields of Study & Subjects

Trauma Hemostasis Coagulopathy Resuscitation Blood transfusion and management Hemostasis and retained surgical items

Publication details

Journal / source
IntechOpen eBooks
Publication date
26 August 2026
Language
EN
Document type
Book chapter